Here’s what you should know:
1. The beta-1,4-galactosyltransferase-V protein increased in human CRC tumor cells, but not in healthy tissue.
2. As the protein’s activity increased, its resulting product, lactosylceramide, led to the creation of new cells and blood vessels that can spread cancer.
3. When researchers stopped the protein, it halted CRC proliferation.
4. Researchers published their findings in Biochemical and Biophysical Research Communication.
More articles on gastroenterology:
The PE arms race — From the deal heard round the world to what’s next in GI
The strategy behind Pardee UNC’s $16M ASC
ASC supply chain tip of the day: Find an accountability structure
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
